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Abstract 
Regulation of biomedical research is a complex task, including ethical 
aspects subdivided into issues related to research on humans and laboratory 
animals. Involvement of human subjects is under the strict guidance of 
relevant regulatory documents common to most countries. Regarding animals, 
these aspects may vary significantly in nations with different socio political 
and economic factors of transition. From the other side, contemporary 
biomedical research suggests, amongst other, close collaboration of scientific 
and educational institutions from different countries. In Georgia-like countries 
in transition, this process requires significant amendments to the legislation of 
biomedical research, as international state-of-the-art regulations require, on 
one hand, compliance with proper guidelines for use of laboratory animals 
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involved in the research process, and on the other — relevant vivarium 
infrastructure and qualified staff. The current study aimed to collect opinions 
and experiences from the corresponding Georgian institutions and identify and 
propose step-by-step solutions to overcome existing challenges. To achieve 
the goal, we compiled a questionnaire about the management, conduction, and 
monitoring of biomedical research and sent it to relevant organizations. 
Questions concerning an institutional policy on the use of laboratory animals, 
staff qualifications, and infrastructure of units for animal housing/breeding 
(vivariums or similar), were included as well. The survey revealed the major 
gaps, among which yet absent national legislative framework appeared of 
greatest importance, as it allows most institutions’ authorities not to perceive 
the need to adopt accepted standards at their level. This leads to a decreased 
credibility of the research, and forces scientists to use international regulations 
that are quite challenging because of the current state of scientific 
infrastructure in countries in transition. To overcome the identified problems, 
we have proposed several solutions, such as a universal package of 
institutional regulations and a draft amendment to the existing legislation to 
form a national policy on animal welfare.  
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Introduction 
At the present stage of development of biomedical science, its clinical 
and theoretical sections cannot develop without experimental research. So, at 
a certain stage of research (so called phase I and II of clinical trials), it is 
common practice to assess the properties and effectiveness of a new drug, 
vaccine and/or medical device, the result of which cannot be reliably predicted 
on a person, through experimental testing, in other words, deliberately subject 
a person even a group of people to unknown, possibly dangerous influences. 
As this is contrary to Article 3 (“Prohibition of torture”) and Article 5 (“Right 
to liberty and security”) of the European Convention on Human Rights, which 
suggests that no one can be subject to medical, scientific or other experiments 
without voluntary consent, the researchers are obliged to initially conduct 
experiments on laboratory animals to minimize the risk of harmful effects on 
the human body. 
The issue remains relevant, despite the development of information 
technology and the constant expansion of the capabilities of artificial 
intelligence, an increase in the number of software products aimed at 
simulating certain biological processes by means of mathematical algorithms 
(Mager et al., 2001; van der Graaf et al., 2016; Jean-Quartier et al., 2018; 
Cortesi et al., 2020). The main problem of creating such systems is a large 
number of interrelated processes occurring in a macroorganism, the variability 
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of changes and the mutual influence of which is still quite difficult to 
algorithmize (e.g., blood rheology, the effect of drugs on the body as a whole, 
etc.) due to insufficient factual knowledge about them (Gawrylewski,  2007; 
Fisher et al., 2018; Fabian et al., 2019). Considering the above, a researcher is 
forced to turn for a kind of "help" to laboratory animals.  
In turn, the use of animals in biomedical research is one of the most 
important international ethical issues of contemporary science and the 
question of the human attitude towards animals has often been raised. 
Nowadays in science there are two conflicting key imperatives: freedom of 
scientific research on one hand, on the other, the need to restrict this freedom 
in the interests of man (Rogozea et al., 2014; Guidotti, 2017).  Moreover, the 
rapid progress in the creation of products and technologies, and on the other 
hand, the lack of tools for resolving bioethical conflict causes disproportions 
and contradictions when using animals in experiments. Taking this into 
account, the only mechanism for their resolution is the application of 
regulatory measures - a task that should be set by state structures, public 
institutions, and professional associations. 
Currently, the basic principles of working with laboratory animals are 
“Directive 2010/63/EU of the European Parliament and of the Council of the 
European Union of 22 September 2010 on the protection of animals used for 
scientific purposes” and the “Guide for the Care and Use of Laboratory 
Animals” in which only in relation to ethical standards, the requirements for 
the very procedure for the ethical examination of conducted research, methods 
of euthanasia, requirements for the special education of personnel are 
described in detail and strictly regulated, the procedures are classified 
according to the degree of severity depending on the level of the perceived 
pain and suffering inflicted on the animal during the procedure. These 
standards are mandatory for scientists of the USA and all countries of 
European Union, however, in Georgia-like countries in transition they often 
do not have the force of the law. 
Nevertheless, the influence of international standards on the work of 
local researchers is realized through the requirements of the vast majority of 
scientific journals to comply with the rules set out in aforesaid regulations.  
Due to the fact that, when performing scientific research, scientists are obliged 
to publish the results obtained in peer-reviewed journals, the requirements of 
the above Directive and Guide actually become mandatory. 
 
Methods 
The Georgian Association for Laboratory Animal Science (GALAS) 
compiled and distributed the questionnaire among Georgian universities and 
research institutions. Existing structural units that use laboratory animals for 
educational purposes, fundamental or applied research served as a criterion to 
European Scientific Journal, ESJ              ISSN: 1857-7881 (Print) e - ISSN 1857-7431              June 2021 
Special Edition: Actual Problems of Medicine and Dentistry 
www.eujournal.org                                                                                                                             44 
include in the survey. The questionnaire comprised several modules related to 
institutional policy on animal welfare, conduction, monitoring of biomedical 
studies, and the state of the infrastructural units (vivariums, labs, etc.), and 
qualification of the personnel. After the analysis of results and consultations 
with international experts, we have drafted a regulations package both for 
research and governmental entities.    
 
Results  
Analysis of the questionnaire revealed major gaps: i)  each research 
institution was operating on their own considerations, ii) no state policy on use 
and care of laboratory animals existed; iii) scientists are forced to be 
temporarily guided by international regulations that sometimes is very 
challenging; iv) the absence of legislative basis along with mostly amortized 
animal facilities and equipment has negative impact on participation in 
international scientific projects, obtaining funding for the research, as well as 
publishing in peer reviewed journals, due to non-compliance with 
internationally accepted standards and hence lack of credibility of results; v) 
an absence of registration or licensing requirements makes it a challenge to 
definitively identify all the institutes that are currently using animals in this 
country. 
 
Figure 1. Suggested  Legislative  System for Animal Care and Use 
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NCDC -  National Center for Disease Control and Public Health of 
Georgia; MLHSA - Ministry of Internally Displaced Persons from Occupied 
Territories, Labor, Health and Social Affairs of Georgia; SRSNSFG – Shota 
Rustaveli National Science Foundation of Georgia; MES – Ministry of 
Education, Science, Culture and Sport of Georgia; IACUC – Institutional 
Animal Care and Use Committee; GALAS - Georgian Association for 
Laboratory Animal Science. 
Considering various opinions about adaptation and implementation of 
international standards for biomedical research in Georgia and based on 
objective reality, on the first stage the Inter Institutional Animal Care and Use 
Committee at National Center for Disease Control and Public Health of 
Georgia (NCDC) has been established that now allows researchers to conduct 
and monitor all studies in accordance with international animal biosafety level 
(ABSL-2/ABSL-3) standards. Memorandums of Collaboration were signed 
between GALAS and major Georgian biomedical institutions, including the 
National Center for Disease Control and Prevention, Center for Experimental 
Biomedicine, Laboratory of Ministry of Agriculture, and Tbilisi State 
University. The above-mentioned institutions were provided with a unified set 
of regulatory documents regarding contemporary ethical standards and 
regulations in animal housing, nutrition and routine operations. In addition, 
several workshops were held for institutional personnel to increase their 
competence in ethical issues, and a draft of appropriate amendments to 
Georgian legislation is ready for submission to the Parliamentary Committee 
on Science and Education (Fig. 1). 
 
Conclusion 
Establishment and implementation of Georgian standards for the care 
and use of research animals harmonized with those of the international 
biomedical research community will raise the quality and credibility of 
biomedical research in Georgia and facilitate the involvement of the Georgian 
scientific projects in international collaboration.  
The ratification of the European Convention for the Protection of 
Vertebrate Animals used for experimental and other scientific purposes, along 
with the phased implementation of the fundamental provisions of EU 
Directive 2010/63/, remain among the primary objectives for further success 
and recognition of Georgian biomedical science.  
To our knowledge, the presented work is the first study ever carried 
out in the countries of the former Soviet Union. Considering the fact that the 
problems raised in the work are common to these states, the authors suggest 
that proposed approach may be useful for optimizing biomedical research in 
Georgia-like countries in transition. 
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Disclaimer  
The opinions and views expressed herein belong to the authors and do 
not reflect an official position of any other organization. 
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